logo
15:56 May 26

Eris Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1361.40
+7.90 (+0.58%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Eris Lifesciences Ltd. Financials

Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1361.40
+7.90 (+0.58%)
15:56 May 26
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

39/100
Technically Neutral

Strength

8

Weakness

4

Opportunity

1

Threats

1

15.87 %

ROE %

8.41 %

ROA %

44.71

EPS

281.78

BVPS

19.79 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1347.04 1685.15 2009.14 2893.64 3129.42
Operating Expenses +
862.09 1148.4 1334.32 1876.44 2009.31
Raw Material
259.29 348.53 379.33 749.46 817.21
Increase Decrease in Cost
-0.78 3.82 0.72 -35.47 -21.61
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
252.25 346.16 403.82 505.09 556.81
Miscellaneous Expenses
634.77 862.55 953.49 1603.6 1638.02
Operating Profit
484.95 536.75 674.82 1017.2 1120.11
Other Income
26.09 11.15 23.82 18.36 7.75
Depreciation
64.7 117.09 182.6 315.46 279.5
Interest
4.15 26.17 84.8 231.29 192.67
Profit before tax and exceptio..
442.2 404.64 431.24 488.81 655.69
Exceptional Items
0 0 0 0 -17.24
PBT
442.2 404.64 431.24 488.81 638.45
Provision for Taxation
36.41 30.48 34.18 114.2 -8.97
Net Profit
405.79 374.16 397.05 374.61 647.42
NET Profit after MI
406.11 382.16 391.98 351.84 619.52
EPS
29.89 28.1 28.82 25.81 45.33
Operating Profit Margin (%)
36 31.85 33.59 35.15 35.79
Net Profit Margin (%)
30.15 22.68 19.51 12.16 19.8

Eris Lifesciences Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: